News

European Migraine Day of Action 2017

  Next 12th of September 2017 will take place the European Migraine Day of action. The first ever European migraine day of action took place on 2006. Various patient support representatives, and patient organization throughout Europe are working to make the day a success. People live with migraine but no one knows about it. Migraine needs …

European Migraine Day of Action 2017 Read More »

Improving Health Global Patient Meeting – TEVA

Improving Health, Global Patient Advocacy Dialogue meeting; Monday 25th and Tuesday 26th September at the Teva office in Amsterdam. The meeting will be hosted at Teva’s Amsterdam office which is located at Piet Heinkade 107, 1019 GM Amsterdam, The Netherlands Draft Agenda Monday 25th September 2017 10.00 – 12noon Welcome, Introductions Recap from March Mtg, Washington DC 12noon – 1pm Lunch 1.00 – 3.30pm Patient Policy: What …

Improving Health Global Patient Meeting – TEVA Read More »

Novartis announces AMG 334 significantly reduces patients’ monthly migraine days in phase II study of chronic migraine prevention

Phase II 20120295 study of AMG 334 met primary endpoint, confirming efficacy and safety in patients with chronic migraine over 12 weeks of treatment Migraine is a leading cause of disability, affecting more than 10% of people worldwide – within the overall migraine population, people with chronic migraine experience the greatest impact on daily activities …

Novartis announces AMG 334 significantly reduces patients’ monthly migraine days in phase II study of chronic migraine prevention Read More »

Cluster Headache

Often called ‘suicide headaches’, around 130,000 people in the UK suffer from the debilitating condition, cluster headaches. They are excruciating attacks of pain on one side of the head. The pain can be so bad that sufferers sometimes harm themselves to distract themselves from the pain. Now, a new study has been launched to try …

Cluster Headache Read More »

Scroll to Top